Metabolic Solutions Development Company
Kalamazoo, Michigan
Formed in 2006, Metabolic Solutions is developing innovative therapeutics
to address the growing global threat of type 2 diabetes. Its founders are
two scientists with decades of experience in diabetes research. The company’s
solutions use a new pharmacological path to treat diabetes and related symptoms
of metabolic syndrome. This new approach seeks to improve the efficacy of treatment
by freeing patients from the adverse side effects of current treatments.
More information...
Tolera Therapeutics, Inc.
Kalamazoo, Michigan
Formed in 2006, Tolera Therapeutics is developing targeted therapies for
immune suppression and immune tolerance, designed for use in organ transplant
surgeries and other medical settings requiring safer, more targeted immune
modulation. The goal is to provide improved induction therapy with a significantly
better safety profile than current treatment options. The company’s technology,
which stems from organ transplant research done at the Cleveland Clinic, has been
undergoing clinical research and has been tested in humans. The regulatory pathway
is expected to bring a product to market in 2012.
More information...
TransCorp Medical, Inc.
Holland, Michigan
TransCorp Medical is developing products for minimally invasive, motion-preserving
spinal surgery. The company was formed in 2008.
MIDA, LLC
MIDA, LLC is a research and development drug therapeutic company focused on novel
infectious disease indications.
Other Investments
Hopen Therapeutics is in the due diligence process with other promising opportunities.
We have invested in studies to learn more about the feasibility of each, and as the results
come in, we will decide whether to make longer-term investments. Please watch this page for updates.
|
|
|
|